Bookbuilding IPO | ₹650 Cr | Listed at BSE, NSE | Wed, Mar 16, 2016 - Fri, Mar 18, 2016
Healthcare Global IPO is a book build issue of ₹649.64 crores. The issue is a combination of fresh issue of 1.16 crore shares aggregating to ₹252.88 crores and offer for sale of 1.82 crore shares aggregating to ₹396.76 crores.
Healthcare Global IPO bidding started from Mar 16, 2016 and ended on Mar 18, 2016. The shares got listed on BSE, NSE on Mar 30, 2016.
Healthcare Global IPO price band is set at ₹218 per share. The lot size for an application is 65. The minimum amount of investment required by an retail is ₹14,170 (65 shares) (based on upper price). The lot size investment for sNII is 15 lots (975 shares), amounting to ₹2,12,550, and for bNII, it is 71 lots (4,615 shares), amounting to ₹10,06,070.
Edelweiss Financial Services Ltd. is the book running lead manager and Kfin Technologies Ltd. is the registrar of the issue.
Refer to Healthcare Global IPO RHP for detailed Information.
IPO Open
Wed, Mar 16, 2016
IPO Close
Fri, Mar 18, 2016
Issue Price
₹218 per share
Market Cap (Pre-IPO)
₹1,854.66 Cr
| IPO Date | 16 to 18 Mar, 2016 |
| Listed on | Wed, Mar 30, 2016 |
| Face Value | ₹10 per share |
| Price Band | ₹205 to ₹218 |
| Issue Price | ₹218 per share |
| Lot Size | 65 Shares |
| Sale Type | Fresh capital cum OFS |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE, NSE |
| Total Issue Size | 2,98,00,000 shares (agg. up to ₹650 Cr) |
| Fresh Issue | 1,16,00,000 shares (agg. up to ₹253 Cr) |
| Offer for Sale | 1,82,00,000 shares of ₹10 (agg. up to ₹397 Cr) |
| Share Holding Pre Issue | 7,34,75,986 shares |
| Share Holding Post Issue | 8,50,75,986 shares |
| BSE Script Code / NSE Symbol | 539787 / HCG |
| ISIN | INE075I01017 |
Healthcare Global IPO comprises a total issue size of 2,98,00,000 shares. Out of which, 2,23,50,000 (75.00%) are allocated to QIB, 44,70,000 (15.00%) allocated to NII 29,80,000 (10.00%) allocated to RII.
| Investor Category | Shares Offered | % of Total Issue | Max Allottees |
|---|---|---|---|
| QIB Shares Offered | 2,23,50,000 | 75.00% | NA |
| − Anchor Investor Shares Offered | 1,34,10,000 | 45.00% | NA |
| − QIB (Ex. Anchor) Shares Offered | 89,40,000 | 30.00% | NA |
| NII (HNI) Shares Offered | 44,70,000 | 15.00% | NA |
| Retail Shares Offered | 29,80,000 | 10.00% | 45,846 |
| Total Shares Offered | 2,98,00,000 | 100.00% |
Investors can bid for a minimum of 65 shares and in multiples thereof.
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 65 | ₹14,170 |
| Retail (Max) | 14 | 910 | ₹1,98,380 |
| S-HNI (Min) | 15 | 975 | ₹2,12,550 |
| S-HNI (Max) | 70 | 4,550 | ₹9,91,900 |
| B-HNI (Min) | 71 | 4,615 | ₹10,06,070 |
Healthcare Global Enterprises Ltd (HCG) is Bangalore India based provider of speciality healthcare in India focused on cancer and fertility.
HCG operates the largest cancer care network in India in terms of the total number of private cancer treatment centres licensed. HCG also operates fertility centres under the 'Milann' brand.
As of December 31, 2015, HCG network consisted of 14 comprehensive cancer centres, including centre of excellence in Bengaluru, three freestanding diagnostic centres and one day care chemotherapy centre across India.
HCG acquired 50.10% equity in BACC Healthcare in 2013 which operates fertility centres under the Milann brand, through itself and its wholly-owned subsidiary, DKR Healthcare. HCG now operate four Milann fertility centres in Bengaluru. BACC Healthcare is led by a team of qualified and experienced fertility specialists. Its founder, Dr. Kamini Rao has a successful track record of over 25 years of providing fertility treatments. Milann fertility centres provide comprehensive reproductive medicine services, including assisted reproduction, gynaecological endoscopy and fertility preservation; and follow a multidisciplinary and technology-focused approach to diagnosis and treatment.
Under Triesta brand, HCG provide clinical reference laboratory services in India with a specialisation in oncology, including molecular diagnostic services and genomic testing. Triesta central reference laboratory is located in centre of excellence in Bengaluru.
Strengths of the Company:
1. Largest provider of cancer care in India with a proven track record
2. High quality cancer care provided at a competitive price
3. Entry into high potential fertility business
4. Strong management team with successful track record
5. Highly skilled specialist physicians
6. 'hub and spoke' business model and partnership arrangements
| Period Ended |
|---|
| Amount in ₹ Crore |
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Purchase of medical equipment | 42.21 |
| 2 | Investment in IT software, services and hardware | 30.19 |
| 3 | Pre-payment of debt | 147.05 |
| 4 | General corporate purposes | 19.77 |
The Healthcare Global IPO is subscribed 1.56 times on March 18, 2016 1:00:00 PM (Day 3). The public issue subscribed 0.83 times in the retail category, 2.36 times in the QIB category, and 0.43 times in the NII category. Check Day by Day Subscription Details (Live Status)
| Category | Subscription (times) | Shares Offered | Shares bid for |
|---|---|---|---|
| QIB | 2.36 | 89,40,000 | |
| NII | 0.43 | 44,70,000 | |
| Retail | 0.83 | 29,80,000 | |
| Total | 1.56 | 1,63,90,000 |
| # | Issue Expenses | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Payment to BRLMs (including underwriting commission, brokerage and selling commission) | 19.79 |
| 2 | Commission and processing fees for SCSBs | 0.02 |
| 3 | Brokerage and selling commission for Registered Brokers RTAs and CDPs | 0.31 |
| 4 | Registrar to the Offer | 0.05 |
| 5 | Other advisers to the Offer | 7.23 |
| 6 | Banker to the Offer | 0.02 |
| 7 | Listing fees, printing & stationery, advertising & marketing, and Miscellaneous | 7.59 |
| Price Details | BSE | NSE |
|---|---|---|
| Final Issue Price | ₹218.00 | ₹218.00 |
| Open | ₹209.80 | ₹210.20 |
| Low | ₹169.00 | ₹169.10 |
| High | ₹211.00 | ₹211.90 |
| Last Trade | ₹170.95 | ₹171.00 |
Lead Manager Reports
Healthcare Global IPO is a main-board IPO of 2,98,00,000 equity shares of the face value of ₹10 aggregating up to ₹650 Crores. The issue is priced at ₹218 per share. The minimum order quantity is 65.
The IPO opens on Wed, Mar 16, 2016, and closes on Fri, Mar 18, 2016.
Kfin Technologies Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in Healthcare Global IPO using UPI as a payment gateway. Zerodha customers can apply in Healthcare Global IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in Healthcare Global IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The Healthcare Global IPO opens on Wed, Mar 16, 2016 and closes on Fri, Mar 18, 2016.
Healthcare Global IPO lot size is 65, and the minimum amount required for application is ₹14,170.
You can apply in Healthcare Global IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for Healthcare Global IPO will be done on [.], and the allotted shares will be credited to your demat account by . Check the Healthcare Global IPO allotment status.
The Healthcare Global IPO listing date is on Wed, Mar 30, 2016.
